학술논문

Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis.
Document Type
Article
Source
Gut; Feb2023, Vol. 72 Issue 2, p256-263, 8p
Subject
ADENOMATOUS polyposis coli
ADENOMATOUS polyps
ERLOTINIB
POLYPS
Language
ISSN
00175749